Metabolic & Endocrine
Premature Ovarian Failure
0
Pipeline Programs↗
0
Active Trials↗
0
Companies Involved↗
Premature Ovarian Failure is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
11
clinical trials
Unknown status6 · 55%
Completed4 · 36%
Withdrawn1 · 9%
Clinical Trials
Trial Activity
11 trials
Hormone Replacement in Young Women With Premature Ovarian Failure
Completed·Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·Phase 2·NCT00001951·250 enrolled
"It is a Real" The First Baby Of Autologous Stem Cell Therapy in Premature Ovarian Failure
Completed·—·Phase 1/2·NCT02372474·112 enrolled
Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure
Unknown status·—·Phase 1/2·NCT02062931·60 enrolled
Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Premature Ovarian Failure (POF)
Unknown status·—·Phase 1/2·NCT03069209·50 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)